Tocilizumab not associated with increased infection risk after CAR T-cell therapy: implications for COVID-19?
MJ Frigault, S Nikiforow, MK Mansour… - Blood, The Journal …, 2020 - ashpublications.org
Blood, The Journal of the American Society of Hematology, 2020•ashpublications.org
COI notes: MJF (consulting with Novartis, Gilead, Celgene, Arcellx. Research grants-
K12CA087723), SN (consulting to Novartis and Kite Pharma), MKM (consulting to Celularity,
GenMark, SmartPharm, Pulsethera, Vericel, Globe Life House; research support from
ThermoFisher Scientific, Genentech), MCP (consulting Bristol-Myers Squibb, Amgen;
research support from Novartis, Kite Pharma, Bristol Myers Squibb).
K12CA087723), SN (consulting to Novartis and Kite Pharma), MKM (consulting to Celularity,
GenMark, SmartPharm, Pulsethera, Vericel, Globe Life House; research support from
ThermoFisher Scientific, Genentech), MCP (consulting Bristol-Myers Squibb, Amgen;
research support from Novartis, Kite Pharma, Bristol Myers Squibb).
COI notes: MJF (consulting with Novartis, Gilead, Celgene, Arcellx. Research grants-K12CA087723), SN (consulting to Novartis and Kite Pharma), MKM (consulting to Celularity, GenMark, SmartPharm, Pulsethera, Vericel, Globe Life House; research support from ThermoFisher Scientific, Genentech), MCP (consulting Bristol-Myers Squibb, Amgen; research support from Novartis, Kite Pharma, Bristol Myers Squibb).
ashpublications.org